Michael Martin Breen - Executive Chairman/Interim CEO, Director at GT Biopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chairman/Interim CEO, Director
Stock Symbol
GTBP on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Martin Breen since 11/12/2023

Holdings reported by Michael Martin Breen for GT Biopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 856K $246K $0.29 Aug 11, 2023 Direct

Transactions reported by Michael Martin Breen for GT Biopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.